North America dominates the global market for uveitis treatment. This is primarily due to rising incidence of uveitis and related disorders, increasing aging population, and growing R&D investments by drug manufacturing companies in the region. Moreover, rising awareness about uveitis is also boosting the growth of the market.

1. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
Persistence Market Research
Global Uveitis Treatment Market Will Reach
US$ 822.5 million by 2020: Persistence
Market Research
Persistence Market Research 1

2. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
Persistence Market Research Released New Market Report “Global Market Study on Uveitis
Treatment: Asia to Witness fastest Growth by 2020,” the global uveitis treatment market was
valued at USD 539.0 million in 2014 and is expected to expand at a CAGR of 7.3% from 2014
to 2020, to reach USD 822.5 million by 2020.
Browse the full Global Market Study on Uveitis Treatment: Asia to Witness fastest Growth by
2020 report at http://www.persistencemarketresearch.com/market-research/uveitis-treatment-
market.asp
Globally, the uveitis treatment market is witnessing significant growth due to increasing
prevalence of uveitis and related complications, and increasing aging population. Moreover,
increasing R&D investments in drug discovery and development, and growing government
initiatives to reduce eye disorders are also driving the growth of the market. However, lack
of awareness about eye disorders, poor primary healthcare infrastructure, and lack of health
insurance in developing countries are inhibiting the growth of the uveitis treatment market.
The global uveitis treatment market is anticipated to grow from an estimated USD 539.0
million in 2014 to USD 822.5 million by 2020 at a CAGR of 7.3% during the forecast period.
In North America, rising incidence of uveitis and related disorders, increasing aging
population, and growing R&D investments by drug manufacturing companies for the
development of innovative products to treat the disease in the region are driving the uveitis
treatment options such as corticosteroids in the market. For instance, in North America,
approximately 500,000 people are affected by uveitis every year; out of these,
approximately 50,000 new blind cases occur due to uveitis, which accounts for
approximately 10% of the overall blind cases in the region.
In Europe, the uveitis treatment market is driven by rising number of autoimmune disorders
such as AIDS and multiple sclerosis. Moreover, in Germany, the market is evolving due to
rising aging population and increasing the prevalence of eye disorders. However, in Asia, the
growth for uveitis treatment is higher than that in developed regions, due to increasing
prevalence of uveitis and growing aging population.
pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc.,
OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals, Inc, and Santen
Pharmaceutical Co., Ltd. are some of the major players in the uveitis treatment market.
Request Sample Report at
http://www.persistencemarketresearch.com/samples/4430
The uveitis treatment market is segmented as follows:
Persistence Market Research 2

3. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
By type
 Anterior uveitis
 Posterior uveitis
 Intermediate uveitis
 Panuveitis
By treatment
 Anti-inflammatory medications
 Antibiotic/Antiviral medications
 Immunosuppressive medications
By geography
 North America
 Europe
 Asia
 Rest of the World (RoW)
Market History:
Globally, the uveitis treatment market is witnessing significant growth due to increasing prevalence of
uveitis and related complications. Moreover, rising aging population, increasing the prevalence of eye
disorders, and growing government initiatives to reduce eye disorders are also driving the growth of the
market. However, lack of awareness about eye disorders, poor primary healthcare infrastructure, and lack
of health insurance in developing countries inhibits the growth of the market. The global uveitis treatment
market is anticipated to grow from an estimated USD 539.0 million in 2014 to USD 822.5 million by 2020
at a CAGR of 7.3% during the forecast period.
North America is the largest market and Asia the fastest growing market for uveitis treatment. In terms of
the type of uveitis, anterior uveitis represents the largest growing segment of this market. Anterior uveitis
refers to inflammation of the middle layer of the eye, which includes the iris and ciliary body. Anterior
uveitis may be acute or chronic in nature. Anterior uveitis is caused mainly due to auto-immune disorders
and bacterial, fungal, or viral infections. The anterior uveitis treatment market was estimated at USD
Persistence Market Research 3

4. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
273.1 million in 2014 and is expected to reach USD 416.3 million by 2020, expanding at a CAGR of 7.3 %
during the forecast period.
Some of the major players in the uveitis treatment market are pSivida Corp., XOMA Corporation, Alcon,
Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated,
Regeneron Pharmaceuticals, Inc, and Santen Pharmaceutical Co., Ltd.
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Assumptions
Chapter 2 Market Synopsis
Chapter 3 Porter’s Five Forces Analysis
3.1 Bargaining Power of Suppliers
Persistence Market Research 4

5. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
3.2 Bargaining Power of Buyers
3.3 Threat of New Entrants
3.4 Threat of Substitutes
3.5 Intensity of Rivalry
Chapter 4 Industry Overview
4.1 Market Definition
4.2 Market drivers
4.2.1 Rising aging population
4.2.2 Increasing incidence of eye disorders
4.2.3 Growing government initiatives to reduce eye disorders
4.2.4 Increasing R&D investments in drug discovery and development
4.3 Impact Analysis of Market Drivers
4.4 Market restraints
4.4.1 Lack of awareness about eye disorders
4.4.2 Poor primary healthcare infrastructure and lack of health insurance in developing
countries
4.5 Impact analysis of market restraints
4.6 Market Trends
Persistence Market Research 5

6. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
4.6.1 Increasing usage of anti-TNF-alpha inhibitor therapy
4.6.2 Rising incidence of drug-induced uveitis
4.7 Market Opportunities
4.7.1 Use of electronic medical records
Chapter 5 Global Market Size and Forecast
Chapter 6 Market Size and Forecast by Type
6.1 Anterior uveitis
6.2 Posterior uveitis
6.3 Intermediate uveitis
6.4 Panuveitis
Chapter 7 Market Size and Forecast by Treatment
7.1 Anti-inflammatory medications
7.2 Antibiotic or antiviral medications
7.3 Immunosuppressive medications
Chapter 8 Market Size and Forecast by Geography
8.1 North America
8.1.1 Scenario in the U.S.
8.2 Europe
Persistence Market Research 6

7. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
8.2.1 Scenario in Germany
8.2.2 Scenario in France
8.2.3 Scenario in the U.K
8.3 Asia
8.3.1 Scenario in Japan
8.3.2 Scenario in China
8.3.3 Scenario in India
Chapter 9 Pipeline Drugs for Uveitis Treatment
9.1 Drugs under development for Uveitis Treatment
Chapter 10 Competitive Scenario
10.1 Competitive Benchmarking
Chapter 11 Company Profiles
11.1 Regeneron Pharmaceuticals, Inc.
11.1.1 Company overview
11.1.2 Products and services
11.1.3 Financial performance
11.1.4 Key developments
Persistence Market Research 7

8. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
11.2 pSivida Corp.
11.2.1 Company overview
11.2.2 Products and services
11.2.3 Financial performance
11.2.4 Key developments
11.3 XOMA Corporation
11.3.1 Company overview
11.3.2 Products and services
11.3.3 Financial performance
11.3.4 Key developments
11.4 Alcon, Inc.
11.4.1 Company overview
11.4.2 Products and services
11.4.3 Financial performance
11.4.4 Key developments
11.5 Allergan, Inc.
11.5.1 Company overview
11.5.2 Products and services
Persistence Market Research 8

9. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
11.5.3 Financial performance
11.5.4 Key developments
11.6 AbbVie Inc.
11.6.1 Company overview
11.6.2 Products and segments
11.6.3 Financial performance
11.6.4 Key developments
11.7 Santen Pharmaceutical Co., Ltd.
11.7.1 Company overview
11.7.2 Products and segments
11.7.3 Financial performance
11.7.4 Key developments
11.8 Enzo Biochem Inc.
11.8.1 Company overview
11.8.2 Products and segments
11.8.3 Financial performance
11.8.4 Key developments
Persistence Market Research 9

10. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
11.9 OphthaliX Inc.
11.9.1 Company overview
11.9.2 Products and segments
11.9.3 Financial performance
11.9.4 Key developments
11.10 Bausch & Lomb Incorporated
11.10.1 Company overview
11.10.2 Products and segments
11.10.3 Financial performance
11.10.4 Key developments
11.11 Artielle ImmunoTherapeutics, Inc.
11.11.1 Company overview
11.11.2 Products and segments
11.11.3 Financial performance
11.11.4 Key developments
11.12 Eyegate Pharmaceuticals, Inc.
11.12.1 Company overview
11.12.2 Products and segments
Persistence Market Research 10

11. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
11.12.3 Financial performance
11.12.4 Key developments
List of Tables
TABLE 1 Market snapshot: Uveitis treatment market, 2014 and 2020
TABLE 2 Drivers for uveitis treatment market: Impact analysis
TABLE 3 Out-of-pocket expenditure of developing and developed countries in 2013
TABLE 4 Restraints for uveitis treatment market: Impact analysis
TABLE 5 Global uveitis treatment market size, by region, 2010 – 2013 (USD million)
TABLE 6 Global uveitis treatment market size, by region, 2014 – 2020 (USD million)
TABLE 7 Global uveitis treatment market size, by type, 2010 – 2013 (USD million)
TABLE 8 Global uveitis treatment market size, by type, 2014 – 2020 (USD million)
TABLE 9 Global uveitis treatment market size, by treatment, 2010 – 2013 (USD million)
TABLE 10 Global uveitis treatment market size, by treatment, 2014 – 2020 (USD million)
TABLE 11 Global anterior uveitis treatment market size, by region, 2010 – 2013 (USD million)
TABLE 12 Global anterior uveitis treatment market size, by region, 2014 – 2020 (USD million)
TABLE 13 Global posterior uveitis treatment market size, by region, 2010 – 2013 (USD
million)
Persistence Market Research 11

12. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
TABLE 14 Global posterior uveitis treatment market size, by region, 2014 – 2020 (USD
million)
TABLE 15 Global intermediate uveitis treatment market size, by region, 2010 – 2013 (USD
million)
TABLE 16 Global intermediate uveitis treatment market size, by region, 2014 – 2020 (USD
million)
TABLE 17 Global panuveitis treatment market size, by region, 2010 – 2013 (USD million)
TABLE 18 Global panuveitis treatment market size, by region, 2014 – 2020 (USD million)
TABLE 19 Global anti-inflammatory medications market size, by region, 2010 – 2013 (USD
million)
TABLE 20 Global anti-inflammatory medications market size, by region, 2014 – 2020 (USD
million)
TABLE 21 Global antibiotic/antiviral medications market size, by region, 2010 – 2013 (USD
million)
TABLE 22 Global antibiotic/antiviral medications market size, by region, 2014 – 2020 (USD
million)
TABLE 23 Global immunosuppressive medications market size, by region, 2010 – 2013 (USD
million)
TABLE 24 Global immunosuppressive medications market size, by region, 2014 – 2020 (USD
million)
TABLE 25 The North American uveitis treatment market size, by country, 2010 – 2013 (USD
million)
Persistence Market Research 12

13. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
TABLE 26 The North American uveitis treatment market size, by country, 2014 – 2020 (USD
million)
TABLE 27 The European uveitis treatment market size, by country, 2010 – 2013 (USD million)
TABLE 28 The European uveitis treatment market size, by country, 2014 – 2020 (USD million)
TABLE 29 The Asian uveitis treatment market size, by country, 2010 – 2013 (USD million)
TABLE 30 The Asian uveitis treatment market size, by country, 2014 – 2020 (USD million)
TABLE 31 Major pipeline drugs for uveitis treatment
TABLE 32 Product category of Regeneron Pharmaceuticals, Inc.
TABLE 33 Product category of pSivida Corp.
TABLE 34 Product category of XOMA Corporation
TABLE 35 Major product categories of Alcon, Inc.
TABLE 36 Major product categories of Allergan, Inc.
TABLE 37 Product segment of AbbVie Inc.
TABLE 38 Major product categories of Santen Pharaceutical Co., Ltd.
TABLE 39 Product segments of Enzo Biochem Inc.
TABLE 40 Product category of OphthaliX Inc.
TABLE 41 Major product categories of Bausch & Lomb Incorporated.
TABLE 42 Product category of Artielle ImmunoTherapeutics, Inc.
Persistence Market Research 13

14. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
TABLE 43 Product category of Eyegate Pharmaceuticals, Inc.
List of Figures
FIG. 1 Uveitis treatment market: Porter’s five forces analysis
FIG. 2 Major types of uveitis treatment
FIG. 3 Aging population in major countries, 2000 – 2050 (% share in total population)
FIG. 4 Global uveitis treatment market share, by region, by value, 2013
FIG. 5 Global uveitis treatment market share, by type, by value, 2013
FIG. 6 Global uveitis treatment market share, by treatment, by value, 2013
FIG. 7 Global anterior uveitis treatment market share, by region, by value, 2013
FIG. 8 Global posterior uveitis treatment market share, by region, by value, 2013
FIG. 9 Global intermediate uveitis treatment market share, by region, by value, 2013
FIG. 10 Global panuveitis treatment market share, by region, by value, 2013
FIG. 11 Global anti-inflammatory medications market share, by region, by value, 2013
FIG. 12 Global antibiotic or antiviral medications market share, by region, by value, 2013
FIG. 13 Global immunosuppressive medications market share, by region, by value, 2013
FIG. 14 The North American uveitis treatment market share, by country, by value, 2013
FIG. 15 The European uveitis treatment market share, by country, by value, 2013
FIG. 16 The Asian uveitis treatment market share, by country, by value, 2013
Persistence Market Research 14

15. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
FIG. 17 Research and development expenditures of major players in the market
FIG. 18 Revenue and net income of Regeneron Pharmaceuticals, Inc., 2012 – 2014 (USD
million)
FIG. 19 Total revenues and net income of pSivida Corp., 2012 – 2014 (USD million)
FIG. 20 Total revenue and net income of XOMA Corporation, 2011 – 2013 (USD million)
FIG. 21 Net sales and operating income of Alcon, Inc., 2011 – 2013 (USD million)
FIG. 22 Total revenues and operating income of Allergan, Inc., 2012 – 2014 (USD million)
FIG. 23 Net sales and net earnings of AbbVie Inc., 2012 – 2014 (USD million)
FIG. 24 Net sales and net income of Santen Pharmaceutical Co., Ltd., 2012 – 2014 (USD
million)
FIG. 25 Revenues and net loss of Enzo Biochem Inc., 2012 – 2014 (USD million)
FIG. 26 Revenues and operating income of Valeant Pharmaceuticals International, Inc., 2012
– 2014 (USD million)
About Us:
Persistence Market Research is a global market research firm specializing- syndicated research,
custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-
service market research firm, we stand committed to bringing more accuracy and speed to your business
decisions. From ready-to-purchase market research reports to customized global research solutions, our
engagement models are highly flexible without compromising on our deep-seated research values. Briefly
stated, our mission is to give you access to forecasts and trends analyses that put you on the path to
profitability.
Persistence Market Research 15

16. Uveitis Treatment Market - Global Study on Uveitis Treatment - Asia to
Witness fastest Growth by 2020
PMR’s Services Go Beyond Gleaning Data
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do
not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar
decision? We strive to deliver both even with demanding deadlines.
Contact Us:
Addie Thomes
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
Persistence Market Research 16